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Abstract
Background: A complex interaction exists between tuberculosis (TB) and human
immunodeficiency virus (HIV) infection at an individual and community level. Limited knowledge
about the rate of HIV infection in TB patients and the general population compromises the planning,
resource allocation and prevention and control activities. The aim of this study was to determine
the rate of HIV infection in TB patients and its correlation with the rate HIV infection in pregnant
women attending antenatal care (ANC) in Southern Ethiopia.
Methods: All TB patients and pregnant women attending health institutions for TB diagnosis and
treatment and ANC were consecutively enrolled in 2004 – 2005. TB diagnosis, treatment and HIV
testing were done according to the national guidelines. Blood samples were collected for
anonymous HIV testing. We used univariate and multivariate logistic regression analysis to
determine the risk factors for HIV infection and linear regression analysis to determine the
correlation between HIV infection in TB patients and pregnant women.
Results: Of the 1308 TB patients enrolled, 226 (18%) (95%CI: 15.8 – 20.0) were HIV positive. The
rate of HIV infection was higher in TB patients from urban 25% (73/298) than rural areas 16% (149/
945) [AOR = 1.78, 95%CI: 1.27–2.48]. Of the 4199 pregnant women attending ANC, 155 (3.8%)
[95%CI: 3.2–4.4] were HIV positive. The rate of HIV infection was higher in pregnant women from
urban (7.5%) (80/1066) than rural areas (2.5%) (75/3025) [OR = 3.19, 95% CI: 2.31–4.41]. In the
study participants attending the same health institutions, the rate of HIV infection in pregnant
women correlated with the rate of HIV infection in TB patients (R2 = 0.732).
Conclusion: The rate of HIV infection in TB patients and pregnant women was higher in study
participants from urban areas. The rate of HIV infection in TB patients was associated with the
prevalence of HIV infection in pregnant women attending ANC.
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The interaction between tuberculosis (TB) and human
immunodeficiency virus (HIV) infection is complex. In
the individual patient, HIV infection weakens the
immune system and increases the susceptibility to TB.
HIV increases the likelihood of reactivation, reinfection
and progression of latent TB infection to active disease. It
also alters the clinical presentation of TB, complicates the
follow up and compromises the response to anti-TB treat-
ment [1].
In a population, the lifetime risk of developing active TB
once infected, in absence of HIV infection, is about 10%
[2]. However, it increases tenfold in HIV infected individ-
uals. This has resulted in a large increase in the number of
TB cases [3,4]. The proportion of smear-negative pulmo-
nary TB (PTB) and extrapulmonary TB (EPTB) is higher
among HIV co-infected TB patients [5].
At TB control programme level, an increase in the TB bur-
den leads to increased need of trained staff, diagnostic
facilities and patient care. The number of smear positive
PTB cases registered has been used as the basis for procure-
ment and distribution of drugs and supplies [6]. However,
changes in the proportion of smear negative PTB and
EPTB due to HIV co-infection may require adjustments. In
Ethiopia, ten per cent of HIV infected people require
antiretroviral therapy and the need is more among TB
patients co-infected with HIV [7]. Therefore, knowledge
about the rate of HIV infection in TB patients might help
in planning and resource allocation. Regular surveillance
of HIV infection in TB patients and the general population
would also help in understanding the spread of the dual
infections and monitoring the performances of TB and
HIV control activities [8,9].
However, knowledge about the prevalence of HIV infec-
tion in the general population and its correlation with the
rate of HIV infection in TB patients is limited in Ethiopia.
The aim of this study was to determine the rate of HIV
infection in TB patients and its correlation with the rate
HIV infection in pregnant women attending antenatal
care (ANC) in Southern Ethiopia.
Methods
Study area and population
This study was conducted in the Southern Nations,
Nationalities and Peoples' Region (SNNPR) of Ethiopia.
The region has 13 administrative zones and an estimated
population of 14 million, of which 93% live in rural areas.
Only half of the population live within two-hour walking
distance from a public health institution. The Regional
Health Bureau has adopted the World Health Organiza-
tion recommended directly observed short course treat-
ment strategy for TB control since 1995. The first round
HIV survey among TB patients and pregnant women was
conducted in 2002 [10]. In this study, the number of sur-
veillance sites was increased to include more urban and
rural communities to represent all zones of the region.
Study design and site selection
This is a cross-sectional study carried out from September
2004 to April 2005.
TB-HIV co-infection survey
Health institutions were selected based on their capacity
to diagnose and treat TB patients. The diagnostic services
included direct sputum microscopy, routine blood tests
and x-rays. Ten health institutions (Figure 1) were ran-
domly selected. All TB patients were consecutively
enrolled at their first visit to the treatment units.
ANC – based HIV sentinel survey
Health institutions that deliver ANC, had an adequate cli-
ent volume, collect blood samples for routine tests such as
haemoglobin determination and syphilis testing and
facilities to maintain cold chain were identified of which
twelve health institutions (Figure 1) were randomly
selected. All pregnant women attending ANC were con-
secutively enrolled at their visit to health institutions [11].
In both surveys, TB patients and pregnant women referred
from other health institutions or coming for the second
visit during the survey period were excluded to avoid rep-
etition. In six of the study sites, both surveys were con-
ducted in the same health institutions providing health
service to TB patients and pregnant women from the same
districts. However, in the remaining sites, the surveys were
conducted in health institutions providing health service
to the population in the nearby districts.
Diagnosis of TB
The diagnosis of TB was based on the recommendations
of the National TB and Leprosy Control Programme [6].
Briefly, patients presenting with symptoms suggestive of
PTB who had productive cough for three weeks or more
with at least two positive sputum smears or one positive
smear and x-ray findings consistent with active PTB were
classified as smear-positive PTB cases. Patients presenting
with cough of three weeks or more with initial three neg-
ative smears and no clinical response to a course of broad-
spectrum antibiotics, three negative smear results after a
course of broad-spectrum antibiotics, x-ray findings con-
sistent with active PTB and decided by a clinician to be
treated with anti-TB chemotherapy were classified as
smear-negative PTB cases. Patients presenting with dry
cough of three weeks or more were diagnosed based on
strong clinical evidence and x-ray findings consistent with
active TB. Patients presenting with symptoms suggestive
of TB other than the lungs, which did not respond to aPage 2 of 8
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nician to be treated with anti-TB chemotherapy were clas-
sified as EPTB cases. In children, TB was diagnosed if there
were symptoms and signs suggestive of TB, contact history
with a known TB patient and x-ray findings consistent
with active TB.
Data and specimen collection
Trained laboratory technicians and health workers from
TB and ANC functions collected the data using pretested
questionnaires. The main variables were age, sex, resi-
dence and survey site for all participants, and disease clas-
sification and category for TB patients. 5 ml of blood
samples were collected from TB patients and pregnant
women. Routine blood tests except for HIV were done
locally and reported to the attending health workers. The
remaining serum samples were stripped off individual
identifying markers and were assigned unique codes. They
were kept at 4°C, transported to the regional Centre for
Health Research Laboratory (CHRL) and stored at – 20°C
until analysis. The serum samples were anonymously
tested for HIV using ELISA test (Vironostica ® Uniform II
Ag/Ab BIOMÉRIEUX). All the samples were sent to the
Ethiopian Health and Nutrition Research Institute
(EHNRI) to repeat ELISA test using Enzygnost Anti-HIV1/
2 Plus (Dade Behring, Germany) and quality control.
ELISA reactive specimens at CHRL and EHNRI were con-
sidered positive and discordant specimens were retested
using similar tests [11,12].
Data analysis
We used SPSS 14.0 (SPSS Inc, Chicago, IL, USA) for data
entry and analysis. We determined the rate of HIV infec-
tion in TB patients and pregnant women. Univariate and
multivariate logistic regression analysis were used to
determine the risk factors for HIV infection in TB patients
and pregnant women. Socio-demographic variables that
were significant by univariate analysis were included in
Map of the Southern Nations, Nationalities and Peoples' Region of Ethiopia showing the survey sites, 2004 – 2005Figure 1
Map of the Southern Nations, Nationalities and Peoples' Region of Ethiopia showing the survey sites, 2004 – 
2005.  Zonal boundary.  Regional boundary.  International boundary.  Regional capital, 
Awassa.  Lake.  TB-HIV survey sites.  ANC-based sentinel survey sites.  Overlapping sites.
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fidence interval by HIV status in TB patients. We also did
linear regression analysis to determine the variation of
HIV infection in TB patients explained by the prevalence
of HIV infection among pregnant women from all study
sites and then for the study participants from the same
health institutions. P-value < 0.05 was considered as sta-
tistically significant.
Ethical clearance
Ethical Review Committee of the Regional Health Bureau
approved the study. Oral informed consent was obtained
for all study participants. The study participants who
wanted to know their HIV status were advised to go to vol-
untary counselling and testing service located within the
health institutions or nearby.
Results
1308 TB patients and 4199 pregnant women were
included in the study. Of the TB patients, 729 (56%) were
men and 569 (44%) were women. 309 (24%) patients
came from urban and 978 (76%) patients from rural
areas. Their mean age was 28.4 years. 544 (42%) patients
had smear-positive PTB, 449 (34%) smear-negative PTB
and 308 (24%) EPTB. The rate of HIV infection in TB
patients was 18% (226/1261) [95%CI: 15.8–20.0] rang-
ing from 8.3% (in Silte zone) to 35.3% (in South Omo
zone). The rate of HIV infection in TB patients was similar
for men and women (OR = 1.00, 95%CI: 0.75 – 1.34).
There was no difference in the rate of HIV infection by TB
disease classification: the rate of HIV infection among
smear-positive PTB cases 17.5% (92/526) was similar to
smear-negative PTB 18.1% (78/432) [OR = 1.048, 95%CI:
0.723–1.519] and EPTB cases 18.2% (54/297) [OR =
1.009, 95%CI: 0.687–1.480]. The rate of HIV infection
was higher in TB patients from urban (24.5%, 73/298)
than rural areas (15.8%, 149/945) [AOR = 1.78, 95%CI:
1.27–2.48] as shown in Table 1 &3.
Of the 4199 pregnant women attending ANC, 3097
(74%) came from rural and 1096 (26%) from urban
areas. Their mean age was 25.7 years. The prevalence of
HIV infection among the pregnant women was 3.8%
(155/4091) [95%CI: 3.2–4.4] ranging from 1.5% (in
Gamo Goffa zone) to 10.5% (in Wolaita zone). The rate
of HIV infection was higher among women from urban
7.5% (80/1066) than rural 2.5% (75/3025) areas [OR =
3.19, 95% CI: 2.31–4.41] (Table 2 &3).
In all survey sites, where both surveys were conducted in
the same as well as in different health institutions, we
found no correlation between the rate of HIV infection
among pregnant women and TB patients (R2 = 0.034).
Briefly, South Omo zone with the highest TB-HIV co-
infection rate did not have higher rate of HIV infection
among pregnant women whereas Silte zone that had the
lowest rate of TB-HIV co-infection did not have the lowest
rate of HIV infection among pregnant women (Table 3).
Table 1: Socio-demographic characteristics and HIV status of TB patients, southern Ethiopia, 2004 – 2005
Variables TB Patients without 
HIV 
(N = 1035), n (%)
TB patients with HIV 
(N = 226), n (%)
OR (95%CI) P-value AOR (95%CI) P-value
Age Mean (SD) 29.24 (9.85) 28.29 (13.77)
Gender Male 581(82.1) 127 (17.9) 1
Female 445 (82.1) 97 (17.9) 0.99 (0.75 – 1.34) 0.985
Residence Rural 796 (84.2) 149 (15.8) 1
Urban 225 (75.5) 73 (24.5) 1.73 (1.26 – 2.38) 1.77 (1.28 – 2.46) 0.001
Age group 0 – 14 109 (90.8) 11 (9.2) 1
15 – 24 344 (88.0) 47 (12.0) 1.35 (0.68 – 2.70) 2.01 (0.54 – 7.49) 0.301
25 – 34 267 (73.4) 97 (26.6) 3.60 (1.86 – 6.98) 2.54 (0.76 – 8.46) 0.129
35 – 44 153 (76.9) 46 (23.1) 2.98 (1.48 – 6.01) 7.10 (2.17 – 23.26) 0.001
45 – 54 113 (86.9) 17 (13.1) 1.76 (0.78 – 3.93) 5.78 (1.72 – 19.38) 0.005
≥ 55 57 (95.0) 3 (5.0) 0.52 (0.14 – 1.95) 3.34 (0.94 – 11.93) 0.063
TB classification PTB +ve 434 (82.5) 92 (17.5) 1
PTB -ve 354 (81.9) 78 (18.1) 1.04 (0.75 – 1.45) 0.82
EPTB 243 (81.8) 54 (18.2) 1.05 (0.72 – 1.52) 0.803
TB category New 956 (82.6) 202 (17.4) 1
RFDO 32 (74.4) 11 (25.6) 1.61(0.79 – 3.24) 0.184
TB = Tuberculosis, HIV = Human immunodeficiency virus, OR = odds ratio, CI = confidence interval, AOR = adjusted OR for age and residence
SD = standard deviation, PTB +ve = smear positive pulmonary TB, PTB -ve = smear negative pulmonary TB, EPTB = extrapulmonary TB, R = 
relapse,
F = failure, D = return after default, O = others. Missing variables: age – 15 (1.2%), sex – 12(0.9%), address – 21(1.6%), disease classification – 
7(0.5%), disease category – 58(4.4%), HIV result – 47(3.6%), sex & HIV result – 58(4.4%), age group and HIV – 61(4.7%), address and HIV – 
21(1.6%), disease classification and HIV – 53(4.1%) and age category and HIV- 61(4.7%).Page 4 of 8
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were conducted in the same health institutions, there was
a strong correlation between the rate of HIV infection
among pregnant women and TB patients (R2 = 0.732).
Upon further analysis by residence, the magnitude of cor-
relation was stronger for study participants from urban
(R2 = 0.998) than rural areas (R2 = 0.546) as shown in
Table 4 and Figure 2. From a linear regression analysis, we
found the equation, prevalence of HIV among pregnant
women = -6.22 + 0.89* the rate of HIV infection in TB
patients. Each per cent increase of HIV seroprevalence in
TB patients corresponded to an increase in seroprevalence
of 0.89% among pregnant women.
Discussion
In the recent decades, the number of TB cases has
increased by several folds especially in sub-Saharan Afri-
can countries. HIV infection is considered the main risk
factor for the increase in the number TB patients and the
proportion of smear-negative and EPTB cases [3,14,15].
The information about the rate of HIV infection among
different groups of a community is important to under-
stand the extent of the problem and to implement appro-
priate prevention and control measures.
In a large representative survey of TB patients in southern
Ethiopia, less than a fifth of them were HIV infected sim-
ilar to other reports from the region [9,16]. Higher TB-HIV
co-infection rates, as high as 47% was reported from Ethi-
opia [17,18]. These studies however were hospital-based
and were conducted in few major towns where the preva-
lence of HIV infection in the general population was
much higher.
In our study, there was no difference in the rate of HIV
infection among TB patients by gender, TB classification
and category. Unlike several other studies which reported
higher rates of HIV infection among smear-negative and
EPTB cases compared to smear-positive cases [3,5,10], we
did not find difference in the rate of HIV infection among
Table 2: Socio-demographic characteristics and HIV status of pregnant women attending ANC, Southern Ethiopia, 2004 – 2005
Variables ANC attendants without HIV 
(N = 3936), n (%)
ANC attendants with HIV 
(N = 155), n (%)
OR (95%CI) P – value
Age Mean (SD) 25.45 (5.25) 25.72 (5.19)
Age group 15 – 24 1547 (96) 64 (4.0) 1
25 – 34 2077 (96.4) 77 (3.6) 0.89 (0.64 – 1.26) 0.525
≥ 35 – 44 312 (95.7) 14 (4.3) 1.09 (0.60 – 1. 96) 0.788
Residence Rural 2950 (97.5) 75 (2.5) 1
Urban 986 (92.5) 80 (7.5) 3.19 (2.31 – 4.41) 0.0001
ANC = antenatal care, HIV = human immunodeficiency virus, OR = odds ratio, CI = confidence interval, SD = standard deviation
Missing variables: age – 6(0.1%), address – 6(0.1%), HIV result – 108(2.6%), age group & HIV – 108(2.6%), address & HIV – 108(2.6%)
Table 3: The rate of HIV infection among TB patients and pregnant women attending antenatal care in southern region of Ethiopia 
2004 – 2005
Survey sites by zones* ANC attendants with HIV % (N) TB patients with HIV % (N) R2† Adjusted R2 P-value‡
Urban survey sites
Sidama zone 9.48 (29/306) 17.84 (38/213)
Wolaita zone 10.53 (26/247) 13.79 (12/87)
Gedeo zone 9.46 (21/222) 18.11 (23/127)
Bench Maji zone 2.25 (8/360) 32.5 (66/203)
South Omo zone 1.72 (7/408) 35.29 (12/34)
Kaffa zone 2.45 (8/326) 26.23 (16/61)
Rural survey sites
Hadiya zone 2.7 (7/259) 9.17 (21/229)
Gurage zone 4.5 (18/400) 13.14 (23/175)
Gamo Goffa zone 1.48 (6/405) 10.61 (7/66)
Silte zone 1.95 (8/411) 8.33 (4/48)
Sheka zone 2.31(8/346)
Kambata Tembaro zone 2.24 (9/401)
All survey sites 0.034 0.034 < 0.001
*The survey sites were areas where we conducted the two surveys in the same and different health institutions.
†R2-coefficient of determination weighed for the number of study participants
‡P-value for adjusted R2 HIV = Human immunodeficiency virus, ANC = Antenatal carePage 5 of 8
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tively low prevalence of HIV infection in the region [13].
Another possible explanation could be under diagnosis or
referral of some smear-negative and EPTB suspects with a
potentially higher risk of HIV infection due to limited
diagnostic facilities.
Although the ANC-based HIV sentinel surveillance has
weaknesses as the results may be affected by low attend-
ance of ANC, exclusion of private clinics, the rate of con-
traceptive use and provides no information about men, it
has been used as a proxy for HIV prevalence in the general
population [9]. In our study, the prevalence of HIV infec-
tion among pregnant women attending ANC was 3.8%.
This was similar to the previous reports from the region
[10] but lower than the reports of sentinel surveillance
from other parts of the country [7] and sub-Saharan Afri-
can countries [19,20]. As expected, the prevalence of HIV
among pregnant women was higher in urban areas than
rural areas; this could be due to the difference in the risk
and rate of HIV infection in urban and rural communities
[21,22].
In our study, the rate of HIV infection in TB patients
strongly correlated with the rate of HIV infection among
pregnant women. This was because HIV is the main risk
factor fuelling TB epidemic. Similarly, countries with high
HIV prevalence in the general population had higher inci-
dence of TB and relatively higher rates of TB-HIV co-infec-
tion.
In southern and eastern Africa, reports have shown an
increase in TB notification rate of 13 cases per 105 popula-
tion per year for each 1% increase in HIV prevalence in
countries with high prevalence of HIV infection [4]. In a
generalized HIV epidemic, the rate of HIV infection
among TB patients is an indicator of the maturity of the
HIV epidemic and predicts the occurrence of new TB cases
at country level [9]. A six per cent increase in the number
of TB cases and high rates of HIV infection among TB
patients over the last two decades were reported from sub-
Saharan Africa. This was shown by a strong correlation
between adult HIV prevalence and TB case notification in
a community; and a higher prevalence of HIV infection in
pregnant women was accompanied by high rate of HIV
infection in TB patients [19]. Similarly, a strong correla-
tion (R2 = 0.77) was reported from Europe [23].
Table 4: The rate of HIV infection among TB patients and pregnant women attending antenatal care in the same health institutions of 
southern region of Ethiopia 2004 – 2005
Survey sites by zones* ANC attendants with HIV % (N) TB patients with HIV % (N) R2† Adjusted R2 P – value
Urban survey sites
Sidama zone 9.48 (29/306) 17.84 (38/213)
Wolaita zone 10.53 (26/247) 13.79 (12/87)
Gedeo zone 9.46 (21/222) 18.11 (23/127)
All urban sites 0.998 0.998 < 0.001
Rural survey sites
Hadiya zone 2.7 (7/259) 9.17 (21/229)
Gurage zone 4.5 (18/400) 13.14 (23/175)
Gamo Goffa zone 1.48 (6/405) 10.61 (7/66)
All rural sites 0.547 0.546 < 0.001
All survey sites 0.732 0.732 < 0.001
*The survey sites were areas where we conducted the two surveys in the same health institutions in a district.
†R2-coefficient of determination weighed for the number of study participants
The association of HIV infection among TB patients and preg-nant women attending a tenatal care in souther  Ethiopia, 2004 – 2005Figure 2
The association of HIV infection among TB patients and preg-
nant women attending antenatal care in southern Ethiopia, 
2004 – 2005.  Urban.  Rural.  Fit line for total.Page 6 of 8
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in pregnant women and TB patients coincided with the
spread and stage of HIV epidemic in a community. This
was reflected by the higher rate of HIV infection among TB
patients and pregnant women in urban areas. This could
be because of matured HIV epidemic in urban areas that
led to an increased number of TB cases and number of
HIV infected TB patients [24,25]. In rural areas, we found
lower correlation possibly due to the low HIV prevalence
in the rural communities [13] and a lag period between
the spread of HIV infection and maturity of the epidemic.
In Zimbabwe, an increase in TB incidence occurred four to
five years after the spread of HIV infection in the commu-
nity [4] and a lag period of seven years was reported from
Kenya [26]. Generally, HIV prevalence surveys in Africa,
Asia and Pacific showed HIV prevalence in TB patients to
be many times higher than that was seen in the general
population [27-29]. Similar to the report from Cameroon,
surveillance of HIV infection in TB patients could be used
as an estimate of the rate of HIV infection in the general
population [30].
Conclusion
The rate of HIV infection in TB patients was associated
with the prevalence of HIV infection among pregnant
women in the general population. The seroprevalence
information for TB patients and pregnant women could
be valuable for planning, monitoring and evaluation of
joint prevention and control activities. The trend and level
of interaction of HIV infection in TB patients and preg-
nant women need further study.
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